Ordering Code | 5087 |
---|---|
Test Name | Quadruple Screen |
Alias | Quad Screen MSAFP/HCG Quant/Estriol/Inhibin A |
Preferred Specimen | Serum |
Preferred Container | SST (Gold) |
Other Specimen/Container | Serum in Plain (Red) |
Optimum Volume | 3 mL |
Collection Instructions | All pertinent information must be filled in on the Requisition Form. Specimen must be collected between 15-20 weeks and 6 days gestation. |
Transport Requirements | Oahu: Refrigerated Airline: Refrigerated |
Specimen Stability | Ambient: 8 Hours Refrigerated: 2 Days Frozen: 1 Month Frozen samples should be thawed only once. DO NOT use frost-free freezers. |
Rejection Criteria | Grossly hemolyzed, Insufficient quantity, Specimen older than stability limits, Gross lipemia, Specimen not collected between 15-20 weeks and 6 days gestation |
Avail. Stat | NO |
Analytic Time | Up to 3 Days |
Methodology | Inhibin A: Enzyme Linked Immunosorbent Assay (ELISA) Refer to individual tests fro HCG, MSAFP, Estriol. |
Reference range(s)
The reference ranges listed below are valid on this date of November 21, 2024.
Component | Age | Male Norm | Male Critical Low | Male Critical High | Female Norm | Female Critical High | Female Critical Low | Units | Add'l info |
---|---|---|---|---|---|---|---|---|---|
Gestational Age | ALL | Wks. | See report. | ||||||
G.A. Based On | ALL | See report. | |||||||
Age At Term | ALL | Yrs. | See report. | ||||||
Weight | ALL | lbs. | See report. | ||||||
Race | ALL | See report. | |||||||
Gestation | ALL | See report. | |||||||
Insulin Dependent Diabetic | ALL | See report. | |||||||
Smoking Status | ALL | See report. | |||||||
Repeat test | ALL | See report. | |||||||
FH of NTD | ALL | See report. | |||||||
FH of Down Syndrome | ALL | See report. | |||||||
AFP | ALL | ng/mL | See report. | ||||||
MOM | ALL | <2.5 | |||||||
Beta-HCG, Total | ALL | IU/mL | See report. | ||||||
MOM | ALL | 0.26-2.49 | |||||||
Unconjugated Estriol | ALL | ng/mL | See report. | ||||||
MOM | ALL | >0.2 | |||||||
Inhibin A, Dimeric | ALL | pg/ml | See report. | ||||||
MOM | ALL | <2.0 | |||||||
Down Syndrome Risk Assessment | ALL | See report. | |||||||
Down Syndrome Age Risk | ALL | <1:365 | |||||||
Down Syndrome Screen Risk | ALL | <1:365 | |||||||
NTD Risk Assessment | ALL | See report. | |||||||
NTD Screen Risk | ALL | <1:484 | |||||||
Trisomy 18 Assessment | ALL | See report. | |||||||
Tri18 Screen Risk | ALL | <1:334 | |||||||
Interpretation | ALL | See report. |